PT-141
PT-141 10 mg Overview
Research Peptide | Melanocortin Receptor & Sexual Health Research
PT-141, also known as Bremelanotide, is a synthetic peptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It has gained significant attention in scientific research for its interaction with the melanocortin receptor system and its potential influence on sexual arousal, libido, and neurological signaling.
Unlike compounds that primarily target vascular pathways, PT-141 acts through central nervous system mechanisms associated with sexual desire and arousal. Its unique mechanism of action makes it a subject of interest in studies examining melanocortin receptor activation, neuroendocrine signaling, and sexual behavior.
Key Research Areas:
Sexual Desire & Arousal: Investigated for its influence on central pathways involved in sexual motivation and arousal.
Melanocortin Receptor Activation: Studied for its interactions with melanocortin receptors, particularly MC3R and MC4R.
Neurological Signaling: Explored for its effects on central nervous system pathways involved in behavioral and physiological responses.
Neuroendocrine Regulation: Research focuses on interactions between melanocortin signaling and hormonal pathways.
Sexual Function Research: Investigated in clinical studies involving sexual desire and arousal disorders.
Product Details:
Peptide: PT-141 (Bremelanotide)
Quantity: 10 mg per vial
Classification: Synthetic melanocortin receptor agonist
Intended Use: Laboratory research only
Research Use Only: This product is intended strictly for laboratory and scientific research purposes. Not for human or veterinary consumption, injection, or therapeutic use. This research product is not FDA-approved for any medical use. Bremelanotide is separately FDA-approved as a prescription medication for a specific indication; this product is not that approved medication.


